Analysed PROPANC BIOPHARMA INC (PPCB:NASDAQ) News Sources
Propanc Biopharma Unveils PRP: A Game-Changing Proenzyme Therapy Poised to Challenge Standard Cancer Treatments in the $3+ Billion Pancreatic Cancer Market
05-02-2026
yahoo.com
Propanc Biopharma Provides Corporate Update and Reports Half Yearly 2025/26 Results
18-02-2026
yahoo.com
Propanc Biopharma’s Lead Asset PRP Shows >85% Tumor Growth Inhibition in Preclinical Pancreatic Models
03-03-2026
yahoo.com
Propanc Biopharma Executes Service Agreement with FyoniBio to Establish & Validate Pharmacokinetics Assay for Phase 1b First-In-Human Study
10-03-2026
yahoo.com
Propanc Biopharma Targets $3B+ Pancreatic Cancer Market with PRP: 85%+ Tumor Inhibition in Breakthrough Proenzyme Therapy
12-03-2026
yahoo.com
Propanc Biopharma Executes Multi-Yr, Anti-Aging & Cancer Research Collaboration with the Universities of Jaén and Granada, Spain
24-03-2026
yahoo.com
Propanc Biopharma Implements Reverse Stock Split to Support Continued Nasdaq Listing and Growth Plans
14-05-2026
yahoo.com
Propanc Biopharma Provides Corporate Update and Reports Third Quarter 2025/26 Results
15-05-2026
yahoo.com
Propanc Biopharma Engages European CDMO for GMP Production of PRP for Phase 1b, FIH Study in 30 – 40 Advanced Cancer Patients
19-05-2026
yahoo.com
What is the current price of PROPANC BIOPHARMA INC (PPCB:NASDAQ)?
The current price of PROPANC BIOPHARMA INC (PPCB:NASDAQ) is $1.62.
PROPANC BIOPHARMA INC (PPCB:NASDAQ) absolute price change since previous trading day?
The absolute price change of PROPANC BIOPHARMA INC (PPCB:NASDAQ) since the previous trading day is $-0.12.
PROPANC BIOPHARMA INC (PPCB:NASDAQ) percentage price change since previous trading day?
The percentage price change of PROPANC BIOPHARMA INC (PPCB:NASDAQ) since the previous trading day is -6.8966%.
What is the most recent average sentiment score for PROPANC BIOPHARMA INC (PPCB:NASDAQ)?
The most recent average sentiment score for PROPANC BIOPHARMA INC (PPCB:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for PROPANC BIOPHARMA INC (PPCB:NASDAQ)?
The most recent sentiment for PROPANC BIOPHARMA INC (PPCB:NASDAQ) is .
SEC-8K** Filing Available For PROPANC BIOPHARMA INC (PPCB:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.